Stay updated on T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.

Latest updates to the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page
- Check3 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the usual content, hiding the trial details, sponsor information, and contacts.SummaryDifference16%

- Check46 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s version. This change does not modify any study details or visible content.SummaryDifference0.0%

- Check53 days agoChange DetectedA line reading '2023 ( U.S. NIH Grant/Contract )' was added to the study details, updating the funding attribution for the DESTINY-Breast09 trial.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a newer build of the site’s software. This generally reflects bug fixes or minor improvements rather than changes to page content.SummaryDifference0.0%

- Check74 days agoChange DetectedNew revision dates have been added to the study's update history, signaling routine updates to the trial record. The listed dates indicate recent modifications were applied to the DESTINY-Breast09 entry.SummaryDifference0.1%

Stay in the know with updates to T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.